Product Information

SIMVASTATIN 40 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0523 per EA under NDC 65862005330. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Dec 20, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SIMVASTATIN 40 MG TABLET

Simvastatin
$0.0523per EA

Strength

40 mg/1

NDC

65862005330

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

SIMVASTATIN

Approval Type

Generic (ANDA)

FDA Application

ANDA077691

FDA Approved

12/20/2006

TE Code

AB

On Market Since

12/20/2006

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for SIMVASTATIN 40 MG TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has risen 34.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0523 per EA
All-time high$0.0701 (Nov 15, 2023)
All-time low$0.0329 (Apr 18, 2018)
52-week high$0.0547
52-week low$0.0523
Median price$0.0415
Average price$0.0444
Largest weekly change+38.4% (Jan 22, 2014)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-2.8%

3M

-2.9%

6M

-3.0%

1Y

+0.7%

3Y

-25.5%

5Y

+16.8%

All

+34.1%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SIMVASTATIN 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SIMVASTATIN 40 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0523 per EA (NDC 65862005330), effective Nov 11, 2026.

How has the price of SIMVASTATIN 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for SIMVASTATIN 40 MG TABLET has risen 34.1%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for SIMVASTATIN 40 MG TABLET?

Since Nov 28, 2013, the NADAC for SIMVASTATIN 40 MG TABLET has ranged from a low of $0.0329 (Apr 18, 2018) to a high of $0.0701 (Nov 15, 2023), with a median of $0.0415 per EA.

Are there cheaper alternatives to SIMVASTATIN 40 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SIMVASTATIN 40 MG TABLET, is $0.0410 per EA — about 22% below SIMVASTATIN 40 MG TABLET.

Who manufactures SIMVASTATIN 40 MG TABLET?

SIMVASTATIN 40 MG TABLET (NDC 65862005330) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.